Stereotaxis Inc.
STXS | AMEX
$1.37
+$0.01 (+0.74%)
Sep 22, 2026, 11:48 AM ET · Market open
Company Profile
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Key Executives
| Name | Position |
|---|---|
| David Leo Fischel | Chief Executive Officer & Chairman |
| Kimberly R. Peery | Chief Financial Officer |
| Keith Galloway | Vice President of Operations |
| Patricia S. Williams | General Counsel & Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 19, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 13, 2026 | EFFECT | Filing |
| Aug 13, 2026 | EFFECT | Filing |
| Aug 13, 2026 | 424B3 | Filing |
| Aug 13, 2026 | 424B3 | Filing |
| Aug 12, 2026 | 10-Q | Quarterly Report |
| Aug 11, 2026 | 8-K | Current Report |
| Jul 16, 2026 | 8-K | Current Report |
| Jul 15, 2026 | S-3 | Filing |
| Jul 15, 2026 | S-3 | Filing |
Stereotaxis Inc.
| Country | United States |
| IPO Date | Aug 11, 2004 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 131 |
| CEO | David L. Fischel |
Contact Details
710 North Tucker Boulevard St. Louis,
Missouri 63101 United States
Stock Details
| Ticker Symbol | STXS |
| Exchange | AMEX |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001289340 |
| CUSIP Number | 85916J409 |
| ISIN Number | US85916J4094 |
| SIC Code | 3845 |
Add to Watchlist
Select watchlists to add or remove STXS